← Back to Provider List

ANGELICA ESTRELLA

Optometrist · LAS VEGAS, NV

2021 N RAINBOW BLVD STE 100, LAS VEGAS, NV 89108

NPI Number
1508486036
Street View of 2021 N RAINBOW BLVD STE 100, LAS VEGAS, NV 89108

Practice location · View on Google Maps

Total Medicaid Payments
$183,070
+1% vs specialty average
Patients Seen
5,430
Total Claims
5,630
$ Per Patient
$34
Specialty avg: $38
Specialty Rank
#71 of 377
Optometrist providers in Nevada
Peer Average
$181,896
Average total for Optometrist
Claims per Patient
1.0
Average visits / services per person

Payments by Year

How much Medicaid paid this provider each year. Large jumps can indicate changes in practice volume or billing patterns.

Year Total Paid % of Max
2020$28,657
2021$45,697
2022$39,214
2023$42,227
2024$27,275

Procedure Code Breakdown

The specific medical services this provider billed Medicaid for. Each HCPCS/CPT code represents a different type of visit, test, or treatment.

HCPCS Code Description Claims Paid % of Total Avg per Claim
V2020Frames, purchases1,756$57,852
31.6%
$33
V2100Sphere, single vision, plano to plus or minus 4.00, per lens1,229$38,863
21.2%
$32
92004Eye exam or vision test831$32,996
18.0%
$40
92014Eye exam or vision test623$25,702
14.0%
$41
92340Eye exam or vision test335$6,197
3.4%
$18
92015Eye exam or vision test340$6,168
3.4%
$18
92060Eye exam or vision test99$5,548
3.0%
$56
99213Office visit for a simple problem (established patient)58$3,829
2.1%
$66
92250Eye exam or vision test25$1,787
1.0%
$71
V2784Lens, polycarbonate or equal, any index, per lens260$1,662
0.9%
$6
99203New patient office visit — moderate problem14$1,407
0.8%
$100
V2103Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens60$1,060
0.6%
$18

About This Data

This data comes from the HHS Medicaid Provider Spending dataset (opendata.hhs.gov). It shows payments made through Nevada Medicaid from 2018–2024. High payments do not mean a provider is doing anything wrong — some specialties naturally cost more, and busy providers see more patients. But unusually high numbers compared to peers can be worth a closer look.